# Arun Rajasekaran

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/arun-rajasekaran/

## Facts

| Field | Value |
| --- | --- |
| Citations | 590 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 8 |
| i10-index | 8 |
| Last Known Institution | San Francisco Foundation |
| OpenAlex ID | https://openalex.org/A5066598327 |
| ORCID iD | 0000-0002-7564-6362 |
| Works | 56 |

## Researcher papers

- [IgA Nephropathy: An Interesting Autoimmune Kidney Disease](https://scholariq.org/papers/iga-nephropathy-an-interesting-autoimmune-kidney-disease/)
- [APOL1 Risk Variants Predict Histopathology and Progression to ESRD in HIV-Related Kidney Disease](https://scholariq.org/papers/apol1-risk-variants-predict-histopathology-and-progression-to-esrd-in-hiv/)
- [An Update on the Current State of Management and Clinical Trials for IgA Nephropathy](https://scholariq.org/papers/an-update-on-the-current-state-of-management-and-clinical-trials-for-iga/)
- [Glucarpidase for treatment of high-dose methotrexate toxicity](https://scholariq.org/papers/glucarpidase-for-treatment-of-high-dose-methotrexate-toxicity/)
- [The Gut and Kidney Crosstalk in Immunoglobulin A Nephropathy](https://scholariq.org/papers/the-gut-and-kidney-crosstalk-in-immunoglobulin-a-nephropathy/)
- [Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy](https://scholariq.org/papers/current-understanding-of-complement-proteins-as-therapeutic-targets-for-the/)
- [Primary myelofibrosis associated glomerulopathy: significant improvement after therapy with ruxolitinib](https://scholariq.org/papers/primary-myelofibrosis-associated-glomerulopathy-significant-improvement-after/)
- [Lactated Ringer's solution and risk of hyperkalemia in patients with reduced kidney function](https://scholariq.org/papers/lactated-ringer-s-solution-and-risk-of-hyperkalemia-in-patients-with-reduced/)
- [Legionnaires' Disease](https://scholariq.org/papers/legionnaires-disease/)
- [Antineutrophil cytoplasmic antibody-associated vasculitis](https://scholariq.org/papers/antineutrophil-cytoplasmic-antibody-associated-vasculitis/)
- [What do clinical trials teach us about the pathophysiology of human IgA nephropathy?](https://scholariq.org/papers/what-do-clinical-trials-teach-us-about-the-pathophysiology-of-human-iga/)
- [Immunoglobulin A Nephropathy: New Treatment Options](https://scholariq.org/papers/immunoglobulin-a-nephropathy-new-treatment-options/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)
- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)

## Researcher university

- [San Francisco Foundation](https://scholariq.org/institutions/san-francisco-foundation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.